MedTrace Logo

Integrative Analysis of Human Glioblastoma Multiforme

NCT03005132 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2016-12-29

No results posted yet for this study

Summary

Integrative analysis of GBM

Conditions

Interventions

OTHER

Normal brain tissue

The investigators will extract total protein, DNA and RNA from the samples.

Sponsors & Collaborators

  • Jilin University

    collaborator OTHER

  • Ganzhou City People's Hospital

    collaborator OTHER

  • Shanghai 10th People's Hospital

    lead OTHER

Principal Investigators

  • Da Fu, PhD · Shanghai 10th People's Hospital

  • Xiaoming Zhong, MD · Ganzhou City People's Hospital

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03005132 on ClinicalTrials.gov